Cite
A prospective study on the effect of endoxifen concentration and CYP2D6 phenotypes on clinical outcome in early stage breast cancer patients receiving adjuvant tamoxifen
MLA
Carolien H. Smorenburg, et al. “A Prospective Study on the Effect of Endoxifen Concentration and CYP2D6 Phenotypes on Clinical Outcome in Early Stage Breast Cancer Patients Receiving Adjuvant Tamoxifen.” Journal of Clinical Oncology, vol. 36, May 2018, p. 523. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........69e47e8df29c5462a1a86cff7ebb08ea&authtype=sso&custid=ns315887.
APA
Carolien H. Smorenburg, Maartje Los, Henk-Jan Guchelaar, Hans Gelderblom, Vincent O. Dezentjé, A B Sanchez-Spitman, Lynn Jongen, Erdogan Batman, Jesse J. Swen, Dirk Jan A.R. Moes, & Patrick Neven. (2018). A prospective study on the effect of endoxifen concentration and CYP2D6 phenotypes on clinical outcome in early stage breast cancer patients receiving adjuvant tamoxifen. Journal of Clinical Oncology, 36, 523.
Chicago
Carolien H. Smorenburg, Maartje Los, Henk-Jan Guchelaar, Hans Gelderblom, Vincent O. Dezentjé, A B Sanchez-Spitman, Lynn Jongen, et al. 2018. “A Prospective Study on the Effect of Endoxifen Concentration and CYP2D6 Phenotypes on Clinical Outcome in Early Stage Breast Cancer Patients Receiving Adjuvant Tamoxifen.” Journal of Clinical Oncology 36 (May): 523. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........69e47e8df29c5462a1a86cff7ebb08ea&authtype=sso&custid=ns315887.